BOSTON, Jan. 14, 2022 /PRNewswire/ -- Environmental
Impact Acquisition Corporation (NASDAQ: ENVI) ("ENVI"), a
publicly-traded special purpose acquisition company, announced
today that ENVI's definitive proxy statement/prospectus (the "Proxy
Statement") relating to the previously announced business
combination with GreenLight Biosciences, Inc. ("GreenLight"), a
biotechnology company focused on RNA research, design, and
manufacturing for human, animal, and plant health, has been filed
with the U.S. Securities and Exchange Commission (the "SEC") on
January 13, 2022.
ENVI has commenced mailing of the Proxy Statement and a notice
and voting instruction form or a proxy card relating to the special
meeting of ENVI stockholders (the "Special Meeting") to ENVI
stockholders of record as of the close of business on December 29, 2021 (the "Record Date"), who will
be entitled to attend and participate in the Special Meeting.
The Special Meeting to approve the proposed business combination
and related matters is scheduled to be held on February 1st, 2022 at 9:00
A.M. Eastern time. The Special Meeting will be conducted
completely virtually, and can be accessed via live webcast at
www.virtualshareholdermeeting.com/ENVI2022SM. If the proposals at
the Special Meeting are approved, the parties anticipate that the
business combination will close and the trading of the combined
entity will commence on NASDAQ shortly thereafter, subject to the
satisfaction or waiver, as applicable, of all other closing
conditions.
The ENVI Board of Directors believes the proposed business
combination is in the best interests of ENVI and its stockholders,
and recommends that ENVI stockholders vote "FOR" the adoption and
approval of the Business Combination Agreement, dated as of
August 10, 2021 (as amended by the
First Amendment to the Business Combination Agreement, dated
July 27, 2021), by and among ENVI,
GreenLight, as well as all other proposals included in ENVI's Proxy
Statement.
Every stockholder's vote is important, regardless of the number
of shares held. Accordingly, ENVI requests that each stockholder
complete, sign, date and return a proxy card (online or by mail) as
soon as possible so that their votes arrive no later than
11:59 P.M. on January 31, 2022, to ensure that the
stockholder's shares will be represented at the Special Meeting.
Stockholders that hold shares in "street name" (i.e., those
stockholders whose shares are held of record by a broker, bank or
other nominee) should contact their broker, bank or nominee to
provide instructions on how to vote their shares and ensure that
their shares are voted.
If any individual ENVI stockholder does not receive the Proxy
Statement, such stockholder should (i) confirm their Proxy
Statement's status with their broker or (ii) contact D.F. King,
ENVI's proxy solicitor, for assistance via e-mail at
ENVI@dfking.com or toll-free call at (866) 620-2535. Banks and
brokers can place a collect call to (212) 269-5550.
ENVI expects to provide stockholders with additional information
on how stockholders may vote their shares on its website in the
coming days.
About GreenLight
Founded in 2008, GreenLight aims to address some of the world's
biggest problems by delivering on the full potential of RNA for
human health and agriculture. In human health, this includes mRNA
vaccines and therapeutics. In agriculture, this includes RNA
to protect honeybees and a range of crops. The company's
breakthrough cell-free RNA manufacturing platform, which is
protected by numerous patents, allows for cost-effective production
of RNA. GreenLight's human health product candidates are in the
pre-clinical stage, and its product candidates for the agriculture
market are in the early stages of development or regulatory review.
For more information, visit
https://www.greenlightbiosciences.com/
In August 2021, GreenLight
Biosciences announced plans to become publicly listed through a
business combination with Environmental Impact Acquisition Corp.
(Nasdaq: ENVI).
For more information, visit greenlightbiosciences.com
About Environmental Impact Acquisition Corporation
Environmental Impact Acquisition Corp. is a Special Purpose
Acquisition Company. The Company is sponsored by CG Investments
Inc. VI, an affiliate of Canaccord Genuity, which manages several
investment vehicles.
Important Information and Where to Find It
ENVI has filed a registration statement on Form S-4 with the
SEC, which includes a document that serves as a preliminary
prospectus and proxy statement of ENVI, referred to as a proxy
statement/prospectus. The registration statement was declared
effective by the SEC on January 13,
2022 and the definitive proxy statement/prospectus and other
relevant documents have been filed with the SEC and mailed to
ENVI's stockholders as of the Record Date.
This press release does not contain all of the information
contained in the final proxy statement/prospectus or other
documents filed with the SEC. Before making any voting decision,
investors and security holders of ENVI are urged to read the
registration statement, the final proxy statement/ prospectus and
all other relevant documents filed or that will be filed with the
SEC in connection with the proposed transaction as they become
available because they will contain important information about the
proposed transaction. Investors and security holders will be
able to obtain free copies of the registration statement, the final
proxy statement/prospectus and all other relevant documents filed
with the SEC by ENVI through the website maintained by the SEC at
www.sec.gov or by sending a written request to ENVI at:
ENVI.Inquiries@cgf.com.
No Offer or Solicitation
This press release shall not constitute a solicitation of a
proxy, consent or authorization with respect to any securities or
in respect of the proposed business combination. This press release
shall also not constitute an offer to sell or the solicitation of
an offer to buy any securities, nor shall there be any sale of
securities in any states or jurisdictions in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such jurisdiction.
No offering of securities shall be made except by means of a
prospectus meeting the requirements of the Securities Act of 1933,
as amended.
Participants in the Solicitation
ENVI, GreenLight and their respective directors and executive
officers may be deemed to be participants in the solicitation of
proxies from ENVI's shareholders in connection with the proposed
transaction. A list of the names of such directors and executive
officers and information regarding their interests in the proposed
business combination are contained in the final proxy
statement/prospectus. You may obtain free copies of these documents
as described above.
Forward-Looking Statements
This press release contains "forward-looking statements" within
the meaning of the safe harbor provisions of the U.S. Private
Securities Litigation Reform Act of 1995, with respect to the
proposed transaction between GreenLight Biosciences, Inc.
("GreenLight") and Environmental Impact Acquisition Corp. ("ENVI").
These forward-looking statements generally are identified by the
words "believe," "project," "expect," "anticipate," "estimate,"
"intend," "strategy," "future," "opportunity," "plan," "may,"
"should," "will," "would," "will be," "will continue," "will likely
result" and similar expressions. Many factors could cause actual
future events to differ materially from the forward-looking
statements in this press release, including but not limited to the
risk that the transaction may not be completed in a timely manner
or at all, which may adversely affect the price of ENVI's
securities and the effect of the announcement or pendency of the
transaction on GreenLight's business relationships, operating
results, and business generally. Forward-looking statements speak
only as of the date they are made. Readers are cautioned not to put
undue reliance on forward-looking statements, and ENVI and
GreenLight assume no obligation and do not intend to update or
revise these forward-looking statements, whether as a result of new
information, future events or otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/envi-and-greenlight-biosciences-announce-filing-of-definitive-proxy-statementprospectus-and-the-february-1st-2022-special-meeting-to-approve-proposed-business-combination-301461291.html
SOURCE GreenLight Biosciences, Inc.
